PR

Prenetics Global LtdNASDAQ PRE Stock Report

Last reporting period 31 Mar, 2022

Updated 27 Nov, 2024

Last price

Market cap $B

0.435

Micro

Exchange

XNAS - Nasdaq

PRE Stock Analysis

PR

Uncovered

Prenetics Global Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.435

Dividend yield

Shares outstanding

110.98 B

Prenetics Global Ltd is a company mainly engaged in the diagnostics and genetic testing business. The Company operates its business through two segments. The Diagnostics segment is engaged in the provision of COVID-19 testing services and operation testing laboratories. The Segment is also engaged in the development of health monitoring systems. The Prevention segment is engaged in the provision of genetics testing services to individuals and corporate entities.

View Section: Eyestock Rating